Lymphoid neoplasms in 17 cattle having tested positive for bovine leukosis virus (BLV) were investigated by histology and immunohistochemistry. In 16 cases, the neoplastic cells were characterized by a marked variation in cell size, atypia in large cells, nuclear irregularity in smaller cells, and nucleolar prominence in cells with scant cytoplasm. These cytological features were used to specifically define pleomorphic lymphomas. In addition to lymphoid cells, immunoblastoid and plasmacytoid cells containing cytoplasmic immunoglobulin G were observed in the remaining case. Since a similar case was recorded as lymphoplasmacytoid lymphoma in a BLV-negative cow, this polymorphic case may not be related to the virus. Most lymphoma cases associated with BLV are classified as pleomorphic, and neoplasms termed enzootic leukosis should be diagnosed based on tumor cell morphology.
Effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on the number and blastogenesis of lymphocytes were evaluated in clinically healthy dogs treated subcutaneously with rhG-CSF at a dose of 2.5 microg/kg for 3 days. Significant increases in the number of leukocytes and segmented neutrophils were observed after the administration of rhG-CSF. The number of lymphocytes also increased on days 1 and 2 after the treatment. Activities of phytohemagglutinin, concanavalin A, and pokeweed mitogen-induced lymphocyte blastogenesis (LB) were augmented to twice the pretreatment levels by the administration of rhG-CSF. These results suggested that administration of rhG-CSF activated lymphocyte functions such as LB in healthy dogs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.